Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KH176 crossover phase IIb study in m.3243A>G mitochondrial disease
NL-OMON49029Phase 2Active, not recruiting
- Sponsor
- Khondrion
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sonlicromanol in Mitochondriopathy (3 arms), sponsored by Khondrion. Primary endpoint: Attention domain score. Started Jan 2020; status: active, not recruiting.
02
Drugs
sonlicromanol
03
Conditions
Mitochondriopathy
Beyond the preview
Go deeper on NL-OMON49029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49029.